Image

Phase II Study of Pembrolizumab in Combination with Carboplatin and Paclitaxel for Advanced or Recurrent Endometrial Adenocarcinoma

Investigating the Effects of an Investigational Medication with Chemotherapy for Advanced Cancer of the Uterus Lining

Recruiting
18 years and older
Female
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the effects of an investigational medication combined with chemotherapy for women with advanced or recurrent endometrial cancer. Endometrial cancer affects the lining of the uterus, and this study aims to understand how the investigational medication, when used with standard chemotherapy drugs, impacts the condition.

Participants in the study will receive the investigational medication along with chemotherapy treatments. Chemotherapy involves using drugs to kill cancer cells, and in this study, it is given in combination with the investigational medication to see if it improves outcomes for patients with this type of cancer.

  • Who can participate: Women with advanced or recurrent cancer of the uterus lining who have undergone surgery and have measurable disease may participate. Participants must be of non-childbearing potential and have an ECOG Performance Status of 0 or 1.
  • Study details: Participants will receive an investigational medication along with chemotherapy to evaluate the treatment's effectiveness.
Print
Study details
    endometrial cancer

TX8472

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.